Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PASSION
DRKS00014595Phase 3Terminated
- Sponsor
- Philipps-Universität Marburg
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in heart failure with preserved ejection fraction (HFpEF) and combined post-capillary and pre-capillary pulmonary hypertension comparing Tadalafil with Placebo (2 arms). Started Jan 2019; status: terminated.
02
Drugs
tadalafil
03
Conditions
heart failure with preserved ejection fraction (HFpEF)combined post-capillary and pre-capillary pulmonary hypertension
Beyond the preview
Go deeper on DRKS00014595.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00014595.